Skip to main content
SpringerLink
Log in

Piper methysticum G.Forst: A Potent Antianxiety Agent

  • Chapter
  • First Online:
Pharmacotherapeutic Potential of Natural Products in Neurological Disorders

  • 663 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Almeida JC, Grimsley EW. Coma from the health food store: interaction between kava and alprazolam. Ann Intern Med. 1996;125:940–1.

    Article  CAS  PubMed  Google Scholar 

  • Balick MJ, Roberta L. Traditional use of sakau (kava) in Pohnpei: lessons for integrative medicine. Alter Thera. 2000;8:96.

    Google Scholar 

  • Bilia AR, Gallon S, Vincieri FF. Kava-kava and anxiety: growing knowledge about the efficacy and safety. Life Sci. 2002;70:2581–97.

    Article  CAS  PubMed  Google Scholar 

  • Boerner RJ, Sommer H, Berger W, Kuhn U, Schmidt U, Mannel M. Kava-kava extract LI 150 is as effective as Opipramol and Buspirone in generalised anxiety disorder--an 8-week randomized, double-blind multi-centre clinical trial in 129 out-patients. Phytomedicine. 2003;10(Suppl 4):38–49.

    Article  PubMed  Google Scholar 

  • Cagnacci A, Arangino S, Renzi A, Zanni AL, Malmusi S, Volpe A. Kava-Kava administration reduces anxiety in perimenopausal women. Maturitas. 2003;44:103–9.

    Article  PubMed  Google Scholar 

  • Chua HC, Christensen ET, Hoestgaard-Jensen K, Hartiadi LY, Ramzan I, Jensen AA, Absalom NL, Chebib M. Kavain, the major constituent of the anxiolytic kava extract, potentiates GABAA receptors: functional characteristics and molecular mechanism. PLoS One. 2016;11:e0157700.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Connor KM, Payne V, Davidson JR. Kava in generalized anxiety disorder: three placebo-controlled trials. Int Clin Psychopharmacol. 2006;21:249–53.

    Article  PubMed  Google Scholar 

  • De Leo V, La Marca A, Lanzetta D, Palazzi S, Torricelli M, Facchini C, Morgante G. Assessment of the association of Kava-Kava extract and hormone replacement therapy in the treatment of postmenopause anxiety. Minerva Ginecol. 2000;52:263–7.

    PubMed  Google Scholar 

  • Dentali SJ. Herb safety review. Kava. Piper methysticum Forster f. (Piperaceae). Boulder: Herb Research Foundation, 1997;29 pp.

    Google Scholar 

  • Dragull K, Yoshida WY, Tang CS. Piperidine alkaloids from Piper methysticum. Phytochemistry. 2003;63:193–8.

    Article  CAS  PubMed  Google Scholar 

  • Feltenstein MW, Lambdin LC, Ganzera M, Ranjith H, Dharmaratne W, Nanayakkara NP, Khan IA, Sufka KJ. Anxiolytic properties of Piper methysticum extract samples and fractions in the chick social-separation-stress procedure. Phytother Res. 2003;17:210–6.

    Article  PubMed  Google Scholar 

  • Furgiele AR, Farnsworth NR, Buckley JP. False-positive alkaloid reactions obtained with extracts of Piper methysticum. J Pharm Sci. 1962;51:1156–62.

    Article  Google Scholar 

  • Garner LF, Klinger JD. Some visual effects caused by the beverage kava. J Ethnopharmacol. 1985;13:307–11.

    Article  CAS  PubMed  Google Scholar 

  • Garrett KM, Basmadjian G, Khan IA, Schaneberg BT, Seale TW. Extracts of kava (Piper methysticum) induce acute anxiolytic-like behavioral changes in mice. Psychopharmacology. 2003;170:33–41.

    Article  CAS  PubMed  Google Scholar 

  • Geier FP, Konstantinowicz T. Kava treatment in patients with anxiety. Phytother Res. 2004;18:297–300.

    Article  CAS  PubMed  Google Scholar 

  • Grunze H, Langosch J, Schirrmacher K, Bingmann D, Von Wegerer J, Walden J. Kava pyrones exert effects on neuronal transmission and transmembraneous cation currents similar to established mood stabilizers-a review. Prog Neuro-Psychopharmacol Biol Psychiatr. 2001;25:1555–70.

    Article  CAS  Google Scholar 

  • Holmes LD. Piper methysticium (kava). The function of kava in modern Samoan culture. Psychopharmacol Bull. 1967;4:9.

    PubMed  CAS  Google Scholar 

  • Kinder C, Cupp MJ. Kava: an herbal sedative. Nurse Pract. 1998;14(156):23.

    Google Scholar 

  • Kinzler E, Krömer J, Lehmann E. Effect of a special kava extract in patients with anxiety-, tension, and excitation states of non-psychotic genesis. Double blind study with placebos over 4 weeks. Arzneimittelforschung. 1991;41:584–8.

    PubMed  CAS  Google Scholar 

  • Klohs MW, Keller F, Willimas RE, et al. A chemical and pharmacological investigation of Piper methysticum Forst. J Medication Pharm Chem. 1959;1:95–103.

    Article  CAS  Google Scholar 

  • Kretschmer W. Kavain as a psychopharmacologic agent. Munch Med Wochenschr. 1970;112:154–8.

    PubMed  CAS  Google Scholar 

  • Kretschmer W. Mental effects of kavain. MMW Munch Med Wochenschr. 1974;116:741–2.

    PubMed  CAS  Google Scholar 

  • Lebot V, Merlin M, Lindstrom L. Kava: The Pacific drug. New Haven: Yale University Press, 1992.; 255 pp.

    Google Scholar 

  • Lehmann E, Kinzler E, Friedemann J. Efficacy of a special Kava extract (Piper methysticum) in patients with states of anxiety, tension and excitedness of non-mental origin – a double-blind placebo-controlled study of four weeks treatment. Phytomedicine. 1996;3:113–9.

    Article  CAS  PubMed  Google Scholar 

  • Lehrl S. Clinical efficacy of kava extracts WS 1490 in sleep disturbances associated with anxiety disorders. Results of a multicenter, randomized, placebo-controlled, double-blind clinical trial. J Affect Disord. 2004;78:101–10.

    Article  PubMed  Google Scholar 

  • Lemert EM. Secular use of kava in Tonga. Q J Stud Alcohol. 1967;28:328–41.

    PubMed  CAS  Google Scholar 

  • Lemert EM. Koni, kona, kava. Orange-beer culture of the Cook Islands. J Stud Alcohol. 1976;37:565–85.

    Article  CAS  PubMed  Google Scholar 

  • Lindenberg D, Pitule-Schödel H. D,L-kavain in comparison with oxazepam in anxiety disorders. A double-blind study of clinical effectiveness. Fortschr Med 1990;108:49–50., 53-4.

    Google Scholar 

  • Meyer HJ. A study of anticonvulsant properties of the kava pyrones dihydromethysticin and dihydrokavain in chemically induced convulsions. Arch Int Pharmacodyn Ther. 1964;150:118–31.

    PubMed  CAS  Google Scholar 

  • Meyer HJ, Meyer-Burg J. Inhibition of electroconvulsions by kava-pyrones dihydromethysticin and dihydrokavain. Arch Int Pharmacodyn Ther. 1964;148:97–110.

    PubMed  CAS  Google Scholar 

  • Müller B, Komorek R. Treatment with Kava-the root to combat stress. Wien Med Wochenschr. 1999;149:197–201.

    PubMed  Google Scholar 

  • Nowakowska E, Ostrowicz A, Chodera A. Kava-kava preparations-alternative anxiolytics. Pol Merkur Lekarski. 1998;4:179–80.

    PubMed  CAS  Google Scholar 

  • Pittler MH, Ernst E. Kava extract for treating anxiety. Cochrane Database Syst Rev. 2002;2:CD003383.

    Google Scholar 

  • Readon E. A drug from Polynesia with central nervous activity: Piper methysticum Forst (“kava-kava”). Gazz Med Ital. 1960;119:231–3.

    Google Scholar 

  • Riesenberg SH. Ancient kava ceremony re-enacted on Pahn Kedira, Ponape. Psychopharmacol Bull. 1967;4:5–8.

    PubMed  CAS  Google Scholar 

  • Saeed SA, Bloch RM, Antonacci DJ. Safety of kava for patients with mild anxiety disorders. Am Fam Physician. 2008;78:433–4.

    PubMed  Google Scholar 

  • Sarris J, Kavanagh DJ, Byrne G, Bone KM, Adams J, Deed G. The Kava Anxiety Depression Spectrum Study (KADSS): a randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum. Psychopharmacology. 2009;205:399–407.

    Article  CAS  PubMed  Google Scholar 

  • Sarris J, Stough C, Bousman CA, Wahid ZT, Murray G, Teschke R, Savage KM, Dowell A, Ng C, Schweitzer I. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study. J Clin Psychopharmacol. 2013;33:643–8.

    Article  PubMed  Google Scholar 

  • Scherer J. Kava-kava extract in anxiety disorders: an outpatient observational study. Adv Ther. 1998;15:261–9.

    PubMed  CAS  Google Scholar 

  • Schliack H. Kavain in diseases of the aged. Hippokrates. 1967;38:26–30.

    PubMed  CAS  Google Scholar 

  • Schmidt N, Ferger B. Neuroprotective effects of (+/−)-kavain in the MPTP mouse model of Parkinson’s disease. Synapse. 2001;40:47–54.

    Article  CAS  PubMed  Google Scholar 

  • Shulgin AT. The narcotic pepper – the chemistry and pharmacology of Piper methysticum and related species. Bull Narc. 1973;25:59–74.

    CAS  Google Scholar 

  • Singh YN, Singh NN. Therapeutic potential of kava in the treatment of anxiety disorders. CNS Drugs. 2002;16:731–43.

    Article  PubMed  Google Scholar 

  • Smith KK, Dharmaratne HR, Feltenstein MW, Broom SL, Roach JT, Nanayakkara NP, Khan IA, Sufka KJ. Anxiolytic effects of kava extract and kavalactones in the chick social separation-stress paradigm. Psychopharmacology. 2001;155:86–90.

    Article  CAS  PubMed  Google Scholar 

  • Tawfiq RA, Nassar NH, El-Eraky WI, El-Denshary S. E. Enhanced efficacy and reduced side effects of diazepam by kava combination. J Adv Res. 2014;5:587–94.

    Article  CAS  PubMed  Google Scholar 

  • Tsutsui R, Shinomiya K, Takeda Y, Obara Y, Kitamura Y, Kamei C. Hypnotic and sleep quality-enhancing properties of kavain in sleep-disturbed rats. J Pharmacol Sci. 2009;111:293–8.

    Article  CAS  PubMed  Google Scholar 

  • Uebelhack R, Franke L, Schewe HJ. Inhibition of platelet MAO-B by kava pyrone-enriched extract from Piper methysticum Forster (kava-kava). Pharmacopsychiatry. 1998;31:187–92.

    Article  CAS  PubMed  Google Scholar 

  • Volz HP, Kieser M. Kava-kava extract WS 1490 versus placebo in anxiety disorders-a randomized placebo-controlled 25-week outpatient trial. Pharmacopsychiatry. 1997;30:1–5.

    Article  CAS  PubMed  Google Scholar 

  • Wagner WL, Herbst DR, Sohmer SH. Manual of the flowering plants of Hawai‘i. 2 vols. Honolulu: University of Hawaii Press & Bishop Museum Press; 1990.

    Google Scholar 

  • Wheatly D. Stress-induced insomnia treated with kava and valerian. Hum Psychopharmacol. 2001;16:353–6.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Herbal Consultant, Mohali, Punjab, India

    Amritpal Singh Saroya

  2. Department of Pharmacology, Sri Guru Ram Das Institute of Medical Science, Amritsar, Punjab, India

    Jaswinder Singh

Authors
  1. Amritpal Singh Saroya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jaswinder Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Saroya, A.S., Singh, J. (2018). Piper methysticum G.Forst: A Potent Antianxiety Agent. In: Pharmacotherapeutic Potential of Natural Products in Neurological Disorders. Springer, Singapore. https://doi.org/10.1007/978-981-13-0289-3_7

Download citation

Publish with us

Policies and ethics

Search

Navigation